QuantaMatrix: QuantaMatrix to Debut on KOSDAQ on Wednesday (12/9) after raising $40.2mn in IPO, at $23.57

QuantaMatrix (CEO Sunghoon Kwon) is an in-vitro diagnostics company specializing in the discovery, development and commercialization of fully-integrated solutions within the sepsis value chain. QuantaMatrix successfully raised $40.2 million through its institutional book-building and retail subscriptions, pricing shares at $23.57, the top of its price band of $18.21 – $23.57. On December 9, QuantaMatrix will list on KOSDAQ and begin trading under the ticker KR 317690.